Tl. Cornelison et al., TAXOL AND PLATINUM CHEMOTHERAPY IN THE TREATMENT OF PANCREATIC AND JEJUNAL CARCINOMA, Journal of surgical oncology, 59(3), 1995, pp. 204-208
Pancreatic cancer and jejunal cancer are aggressive diseases with grim
prognoses. The long term survival of pancreatic carcinoma is still on
e of the worst of ail cancers. Ninety-five percent of the patients die
of their disease within 5 years [Wagener et al: Ann Oncol 5(Suppl 3):
S87-S90, 1994]. Eighty-five percent of patients with jejunal carcinom
a die of their disease within 5 years [Lioe, Biggart: J Clin Pathol 43
:533-536, 1990]. To date, there are disappointingly few effective cyto
toxic agents in the treatment of these cancers. We present a case of a
dvanced-stage pancreatic carcinoma and a case of advanced stage jejuna
l carcinoma, each showing marked response to Taxol and platinum chemot
herapy. (C) 1995 Wiley-Liss, Inc.